KI-Beratung Beta

Produktbild: INTEGRATIVE PANCREATIC INTERVE

INTEGRATIVE PANCREATIC INTERVE

Fr. 248.00

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

18.09.2020

Herausgeber

Ligong Lu + weitere

Verlag

Elsevier Science & Technology

Seitenzahl

622

Maße (L/B/H)

22.9/15.2/3.2 cm

Gewicht

450 g

Sprache

Englisch

ISBN

978-0-12-819402-7

Beschreibung

Portrait

Maoquan Li is Professor in the Department of Interventional and Vascular Therapy at Shanghai Tenth People's Hospital at Tongji University. He specializes in interventional radiology. He was the first interventional radiologist in China to conduct interventional treatment of gastric cancer, adrenal tumors, embolization of uterine fibroids, rheological thrombolytic therapy, interventional comprehensive therapy for diabetic vascular disease, interventional comprehensive treatment for chronic thrombus, and the molecular targeted therapy of aesthetic liver cancer. He is a leader in the field.Ligong Lu is Chief Physician, doctoral tutor, and Dean of Zhuhai Hospital, affiliated with Tongji University. He is deputy director of the Institute of Interventional Vascular Research, and Director of the Zhuhai Intervention Centre, and the Zhuhai Precision Medical Treatment Centre. He is a doctoral tutor at Jinan University, Southern Medical University, and Guangdong Provincial Institute of Cardiovascular Disease, as well as a Professor at Macao University. He has been a senior visiting scholar at the Wayne State University Detroit Medical Center. His research focuses on basic and clinical interventional radiology, liver cancer, and malignancies.Yueyong Xiao is Deputy Director of Radiology at Shanghai Military Hospital. He is Chief Physician, and a doctoral tutor, as well as an executive member of the International Refrigeration Association, and President of the Asian Frozen Society. His work in imaging diagnosis and interventional therapy spans 30 years. He carries out CT and MRI guided minimal invasive surgery. He has been a senior visiting scholar at Harvard Medical College, specializing in CT, and MRI-guided interventional therapy.Deliang Fu is the Director of Pancreatic Surgery at Huashan hospital, affiliated with Fudan University in China, and the Director of the Pancreatic Cancer Treatment Center at Fudan University. He is also deputy director of the Institute of Pancreatic Diseases, also at Fudan University, and vice-chairman of the Pancreas Division of the Shanghai Medical Association, as well as a doctoral tutor. He has published widely in the field, both research papers and book chapters, and has led a number of National Natural Science Foundation and Ministry of Health research projects.Haijun Zhang is Director of the National Engineering Laboratory of Biomedical Material Modification Technology, and deputy director of the Institute of Interventional Vascular Research, at Tongji University in China. He is also Director of the strategic alliance for the medical material modification industry. He focuses on biomedical material modification, including in medical material engineering, medical engineering, and transformational medicine.

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

18.09.2020

Herausgeber

Verlag

Elsevier Science & Technology

Seitenzahl

622

Maße (L/B/H)

22.9/15.2/3.2 cm

Gewicht

450 g

Sprache

Englisch

ISBN

978-0-12-819402-7

EU-Ansprechpartner

Elsevier B.V.
Radarweg 29
1043 NX Amsterdam
NL
productsafety@elsevier.com

Herstelleradresse

Elsevier Science & Technology
London Wall 125
EC2Y 5AS London
GB
tradeorders@elsevier.com

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

Die Leseprobe wird geladen.
  • Produktbild: INTEGRATIVE PANCREATIC INTERVE
  • Part One Basics and transformation research of pancreatic diseases
    1. Anatomy and physiology of pancreas
    2. Epidemiology, pathological anatomy and pathophysiology of pancreatic diseases
    3. Clinical laboratory and imaging diagnosis of pancreatic diseases
    4. Medical therapy of pancreatic diseases
    5. Surgical treatment of pancreatic diseases
    6. Emergency and critical care medicine of pancreatic diseases
    7. Transformation and application advances of pancreatic diseases

    Part Two Interventional therapy for benign pancreatic disease
    8. Clinical interventional therapy for pancreatitis
    9. Clinical interventional therapy for pancreatic cyst
    10. Clinical interventional therapy for pancreatic paracrisis

    Part Three Interventional therapy for malignant pancreatic diseases
    11. Arterial infusion and arterial chemoembolization therapy for pancreatic cancer
    12. Radioactive particles implantation for pancreatic cancer
    13. Radiofrequency and microwave ablation for pancreatic cancer
    14. Nano-knife for pancreatic cancer
    15. HIFU for pancreatic cancer

    Part Four Interventional Therapy for pancreatic cancer-related lesions
    16. Minimally Invasive Interventional treatment for Pancreatic carcinoma induced obstructive jaundice
    17. Minimally Invasive Interventional treatment for Pancreatic carcinoma induced Intestinal Obstruction
    18. Minimally Invasive Interventional treatment for Pancreatic carcinoma induced intractable pain

    Part Five Stem cell and targeted molecular therapy for pancreatic carcinoma
    19. Recent progresses in Stem cell therapy for pancreatic carcinoma
    20. Recent progresses in Targeted molecular therapy for pancreatic carcinoma
    21. Recent progresses in Immunotherapy for pancreatic carcinoma

    Part Six Combined Interventional Therapy for pancreatic carcinoma
    22. Interventional Therapy combined with intravenous chemotherapy pancreatic carcinoma
    23. Interventional Therapy Combined with Radiotherapy for pancreatic carcinoma
    24. Combined Interventional and Targeted Molecular Therapy for Pancreatic Carcinoma
    25. Strategies and Methods for Selecting suitable combined Interventional Therapy for Pancreatic Carcinoma
    26. Recent development and future prospects of Interventional Therapy for Pancreatic Carcinoma